| Volume: | 6,966,874 |
|---|---|
| Day's Low: | $53.71 |
| 52-wk Low: | $52.55 |
| Previous Close: | $59.61 |
| Dividend: | $0.00 |
| Market Cap: | 4,450,400 |
| Avg Volume: | 1,990,800 |
|---|---|
| Day's High: | $55.00 |
| 52-wk High: | $81.35 |
| Open Price: | $54.86 |
| Yield: | 0.00% |
| P/E (Forward): | 10.04 |
| 4:27 PM | 10/27/2009 | Cephalon 3Q Profit Falls 3.1%; Outlook Disappoints |
| 12:59 PM | 10/15/2009 | UPDATE: Senate Panel Passes Bill Limiting Generic Drug Deals |
| 11/23/2009 | Europe drug stocks rally; Cephalon slides |
| 11/23/2009 | This bullish call comes from more than just one analyst. |
| 11/16/2009 | Here's where the experts are placing their bets for next year. |
| 11/3/2009 | SPDR Trust, Cephalon: Money Flow Leaders (SPY, CEPH) |
| 10/31/2009 | Going to Extremes |
| 10/22/2009 | Israel stocks off: Israel Chemicals, Teva in focus |
| 8/4/2009 | Stocks in focus for Wednesday |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.62 | NA | NA |
| EPS, GAAP | 1.31 | 1.42 | -7.75 |
| Consensus Estimate | 1.42 | NA | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 5.82 | 4.82 | 20.75 |
| EPS, GAAP | 3.30 | 3.41 | -3.23 |
| Consensus Estimate | 5.36 | NA | NA |
| CEPH | Industry Average | |
| P/E (TTM) | 18.06 | 81.60 |
| P/E (Forward) | 10.04 | -20.20 |
| PEG Ratio | 0.77 | -1.02 |
| Price/Sales | 2.17 | 3.90 |
| Beta | 0.50 | 0.38 |